Sinopharm Group Co Ltd
Company Profile
Business description
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers.
Contact
No. 385, East Longhua Road
Sinopharm Group Building
Huangpu District
Shanghai200023
CHNSector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2024
Employees
113,635
Sinopharm Group Co Ltd News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,450.90 | 64.30 | -0.76% |
CAC 40 | 7,252.59 | 25.61 | 0.35% |
DAX 40 | 19,107.95 | 74.31 | 0.39% |
Dow JONES (US) | 43,910.98 | 382.15 | -0.86% |
FTSE 100 | 8,054.93 | 29.16 | 0.36% |
HKSE | 19,823.45 | 23.43 | -0.12% |
NASDAQ | 19,281.40 | 17.36 | -0.09% |
Nikkei 225 | 38,721.66 | 654.43 | -1.66% |
NZX 50 Index | 12,674.49 | 74.87 | -0.59% |
S&P 500 | 5,983.99 | 17.36 | -0.29% |
S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
SSE Composite Index | 3,439.28 | 17.31 | 0.51% |